SCHEMBL6690528

SCHEMBL6690528

Nc1cncc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CC(O)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 17/20 0.49
▸ LCK P06239 4/20 0.46
▸ LYN P07948 1/20 0.46
▸ NUDT14 O95848 1/20 0.43
▸ NUDT5 Q9UKK9 1/20 0.43
▸ TNK2 Q07912 1/20 0.42
▸ EGFR P00533 2/20 0.41
▸ SRC P12931 2/20 0.41
▸ KDR P35968 2/20 0.41
▸ TEK Q02763 2/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ PRKCG P05129 1/20 0.41
▸ PRKCB P05771 1/20 0.41
▸ PRKCA P17252 1/20 0.41
▸ PRKCH P24723 1/20 0.41
▸ PRKCI P41743 1/20 0.41
▸ PRKCE Q02156 1/20 0.41
▸ PRKCQ Q04759 1/20 0.41
▸ PRKCZ Q05513 1/20 0.41
▸ PRKCD Q05655 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5818332 0.86 BTK (0.48) BTKLCKLYNNUDT14NUDT5
SCHEMBL6689789 0.85 BTK (0.49) BTKLCKLYNNUDT14NUDT5
SCHEMBL5803835 0.84 BTK (0.50) BTKLCKLYNNUDT14NUDT5
SCHEMBL6685312 0.84 BTK (0.56) BTKLCKLYNNUDT14NUDT5
SCHEMBL6641651 0.83 BTK (0.50) BTKLCKLYNNUDT14NUDT5
SCHEMBL6693408 0.83 BTK (0.56) BTKLCKEGFR
SCHEMBL6623747 0.83 BTK (0.42) BTKLCKLYNNUDT14NUDT5
SCHEMBL5815559 0.82 BTK (0.54) BTKLCKLYNNUDT14NUDT5
SCHEMBL5823682 0.80 BTK (0.59) BTKLCKLYNNUDT14NUDT5
SCHEMBL6638074 0.80 BTK (0.46) BTKLCKLYNNUDT14NUDT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212327-B8 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2004-02-25 — — EP disclosed
EP-1212327-A2 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS BASF AKTIENGESELLSCHAFT (DE) 2002-06-12 — — EP disclosed
WO-2001019829-A2 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS BASF AKTIENGESELLSCHAFT (DE) 2001-03-22 — — WO disclosed
Send feedback